Cited 19 times in
SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with altnernating Sorafenib and Lenvatinib for refractory thyroid cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.